Thermo Fisher Scientific, Inc. vs Johnson & Johnson
TMO vs JNJ — side-by-side comparison from reported financials. TMO leads 1, JNJ leads 9 of 10 comparable metrics.
Thermo Fisher Scientific, Inc.
TMO · Healthcare
$658.02+0.93%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | TMO | JNJ |
|---|---|---|
| Price | $658.02 | $261.79 |
| Market cap | $243B | $631B |
| Revenue (TTM) | $46.3B | $97.9B |
| Revenue growth | -0.3% | +5.6% |
| Net margin | 15.0% | 21.5% |
| Free cash flow | $7.32B | $22.2B |
| Net cash (debt) | ($29.3B) | ($27.8B) |
| 1-year price return | +23.1% | +37.0% |
| P/E | 34.9 | 29.9 |
| P/E vs own history (cheap-side %) | 24% | 16% |
| Dividend yield | 0.27% | 2.00% |
| Return on equity | 13% | 26% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 125,000 | 140,800 |
Full résumé-style profiles: TMO CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.